Tofacitinib in interstitial lung disease complicated with anti-MDA5 antibody-positive dermatomyositis: A literature review

被引:20
作者
Takanashi, Satoshi [1 ]
Kaneko, Yuko [1 ]
Takeuchi, Tsutomu [1 ]
机构
[1] Keio Univ, Sch Med, Dept Internal Med, Div Rheumatol, Tokyo, Japan
关键词
D O I
10.1080/14397595.2021.1906505
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:231 / 237
页数:7
相关论文
共 30 条
[1]   Tofacitinib for the treatment of psoriasis and psoriatic arthritis [J].
Berekmeri, Anna ;
Mahmood, Farrouq ;
Wittmann, Miriam ;
Helliwell, Philip .
EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2018, 14 (09) :719-730
[2]   Tofacitinib in Amyopathic Dermatomyositis-Associated Interstitial Lung Disease [J].
Chen, Zhiwei ;
Wang, Xiaodong ;
Ye, Shuang .
NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (03) :291-293
[3]  
Cohen S., 2020, RMD OPEN, V6, pE001395
[4]   Risk for Herpes Zoster in Tofacitinib-Treated Rheumatoid Arthritis Patients With and Without Concomitant Methotrexate and Glucocorticoids [J].
Curtis, Jeffrey R. ;
Xie, Fenglong ;
Yang, Shuo ;
Bernatsky, Sasha ;
Chen, Lang ;
Yun, Huifeng ;
Winthrop, Kevin .
ARTHRITIS CARE & RESEARCH, 2019, 71 (09) :1249-1254
[5]   Real-world comparative risks of herpes virus infections in tofacitinib and biologic-treated patients with rheumatoid arthritis [J].
Curtis, Jeffrey R. ;
Xie, Fenglong ;
Yun, Huifeng ;
Bernatsky, Sasha ;
Winthrop, Kevin L. .
ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (10) :1843-1847
[6]   The emerging role of Janus kinase inhibitors in the treatment of autoimmune and inflammatory diseases [J].
Damsky, William ;
Peterson, Danielle ;
Ramseier, Julie ;
Al-Bawardy, Badr ;
Chun, Hyung ;
Proctor, Deborah ;
Strand, Vibeke ;
Flavell, Richard A. ;
King, Brett .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (03) :814-826
[7]   Choosing the right biomarkers to predict ILD in myositis [J].
Gono, Takahisa ;
Kuwana, Masataka .
NATURE REVIEWS RHEUMATOLOGY, 2016, 12 (09) :P504-+
[8]   Cytokine profiles in polymyositis and dermatomyositis complicated by rapidly progressive or chronic interstitial lung disease [J].
Gono, Takahisa ;
Kaneko, Hirotaka ;
Kawaguchi, Yasushi ;
Hanaoka, Masanori ;
Kataoka, Sayuri ;
Kuwana, Masataka ;
Takagi, Kae ;
Ichida, Hisae ;
Katsumata, Yasuhiro ;
Ota, Yuko ;
Kawasumi, Hidenaga ;
Yamanaka, Hisashi .
RHEUMATOLOGY, 2014, 53 (12) :2196-2203
[9]  
Groh M, 2015, CLIN EXP RHEUMATOL, V33, P904
[10]  
Hosokawa Y., 2020, J CLIN RHEUMATOL